Wednesday, July 30, 2008

Alzheimer's new drug 'halts' decline

Scientists in Britain have developed a drug which could represent a major breakthrough in treatment for people with Alzheimer's disease, they said on Wednesday. The drug, Rember, targets the build-up of tau protein tangles which form inside the brain nerve cells of people with Alzheimer's.

These tangles destroy nerve cells linked to memory, causing forgetfulness. Professor Claude Wischik of Aberdeen University in northeast Scotland, who co-founded the company which created the drug, hailed the results as "the most significant development in the treatment of the tangles since Alois Alzheimer discovered them in 1907".

read article